Jane Street Group, LLC Mustang Bio, Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.35 - $0.72 $41,671 - $85,723	-119,061 Reduced 83.77%	23,059 $8,000
Q4 2022 Feb 14, 2023	BUY	$0.32 - $8.27 $45,478 - $1.18 Million	142,120 New	142,120 $55,000
Q4 2021 Feb 15, 2022	SELL	$1.66 - $2.64 $20,044 - $31,878	-12,075 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$2.58 - $3.36 $24,350 - $31,711	-9,438 Reduced 43.87%	12,075 $33,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $26,273 - $37,075	9,731 Added 82.59%	21,513 $71,000
Q1 2021 May 18, 2021	SELL	$3.02 - $5.16 $189,190 - $323,253	-62,646 Reduced 84.17%	11,782 $39,000
Q4 2020 Feb 17, 2021	BUY	$2.66 - $4.18 $197,978 - $311,109	74,428 New	74,428 $282,000
Q3 2019 Nov 14, 2019	SELL	$2.74 - $4.65 $87,019 - $147,679	-31,759 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.66 - $6.28 $84,478 - $199,446	31,759 New	31,759 $117,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.